- Repare Therapeutics to Present Initial Phase 1 MINOTAUR Data at ESMO GI Congress 2024
- Repare Therapeutics Provides Business and Clinical Update and Reports First Quarter 2024 Financial Results
- Debiopharm & Repare Therapeutics Announce First Patient Dosed in Phase 1/1b Mythic Trial Evaluating the Synthetic Lethal Combination of WEE1 AND PKMYT1 Inhibition
- Repare Therapeutics & Debiopharm Announce First Patient Dosed in Phase 1/1b MYTHIC Trial Evaluating the Synthetic Lethal Combination of PKMYT1 and WEE1 Inhibition
- Repare Therapeutics Appoints Steven H. Stein, M.D. to its Board of Directors
More ▼
Key statistics
On Friday, Repare Therapeutics Inc (RPTX:NSQ) closed at 3.48, 16.78% above the 52 week low of 2.98 set on Apr 19, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.34 |
---|---|
High | 3.59 |
Low | 3.34 |
Bid | 3.37 |
Offer | 3.58 |
Previous close | 3.35 |
Average volume | 228.24k |
---|---|
Shares outstanding | 42.45m |
Free float | 42.03m |
P/E (TTM) | -- |
Market cap | 147.71m USD |
EPS (TTM) | -1.10 USD |
Data delayed at least 15 minutes, as of May 31 2024 21:00 BST.
More ▼